As the Raf1/MEK/ERK1/2 signaling cascade is causatively involved in frequent diseases such as heart failure and cancer, but also in rare developmental syndromes (so called RASopathies), it is an important therapeutic target1. The gene discussed is RAF1; the disease is heart failure.